Harrisons Formulation Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -3.95%
- Profit Growth 7.28%
- Ebitda -587.10%
- Net Worth 20.20%
- Total Assets 63.51%
About Harrisons Formulation
Harrisons Formulation Private Limited (HFPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 June 2012 and has a history of 12 years and eight months. Its registered office is in Baleswar, Odisha, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rajib Khan and Vikas Gupta serve as directors at the Company.
Company Details
- Location
Baleswar, Odisha, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230OR2012PTC015487
- Company No.
015487
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Harrisons Formulation?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajib Khan  | Managing Director | 07-Jun-2012 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikas Gupta | Additional Director | 29-Aug-2020 | Current |
Financial Performance of Harrisons Formulation.
Harrisons Formulation Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.95% decrease. The company also saw a slight improvement in profitability, with a 7.28% increase in profit. The company's net worth Soared by an impressive increase of 20.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Harrisons Formulation?
Unlock access to Harrisons Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Dear & Dear Laboratories Private LimitedRajib Khan is a mutual person
- Skiniq Aesthetics Private Limited
Vikas Gupta is a mutual person
- Medicaliber Pharmaceutical Private Limited
Vikas Gupta is a mutual person
- Aesthetics Zone Medisys Private Limited
Vikas Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Harrisons Formulation?
Unlock and access historical data on people associated with Harrisons Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Harrisons Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harrisons Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
